Cancer

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

Centessa plans $100m IPO to fund R&D and potential acquisiti...

Centessa has announced plans for a $100m US IPO just weeks after the company launched with $250m in private backing and an R&D powerhouse driven by the merger of 10 biotechs.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J decides against Erleada+Zytiga combination prostate canc...

Johnson & Johnson won’t be filing a prostate cancer therapy combining its Erleada and Zytiga drugs with regulators, after a phase 3 trial showed it didn’t improve survival compared with

Events

Partner Content

Non-Small Cell Lung Cancer Drug Development Summit

Largest solid tumor indication: The definitive forum

News

Activist investor Elliott builds stake in GSK after fresh tr...

Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial results this year raised questions about management’s strategy to t

News

West Chester - Circa November 2020: AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

AZ aims at Pfizer, GSK with potential new PARP cancer drug

AstraZeneca’s Lynparza (olaparib) blazed a trail for the new class of PARP drugs when it was approved in 2014 to treat ovarian cancer.

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Boehringer and MD Anderson extend KRAS cancer collaboration

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations.

Centessa plans $100m IPO to fund R&D and potential acquisiti...

J&J decides against Erleada+Zytiga combination prostate canc...

Non-Small Cell Lung Cancer Drug Development Summit

Activist investor Elliott builds stake in GSK after fresh tr...

AZ aims at Pfizer, GSK with potential new PARP cancer drug

Boehringer and MD Anderson extend KRAS cancer collaboration

AZ's gMG drug Klygefa nears EU approval

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks